Skip to main content
logo
Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
110.33
-0.49 (-0.44%)
Aug 26, 2026, 10:49 AM EDT - Market open

Monopar Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-17.84-13.72-15.59-8.4-10.52-9.1
Loss (Gain) From Sale of Investments
-2.01-0.72-0.01---
Stock-Based Compensation
5.324.841.141.91.641.47
Other Operating Activities
0-4.55---
Change in Accounts Payable
2.370.390.51-1.331.480.4
Change in Other Net Operating Assets
-0.02-2.992.99-0.020.17-0.09
Operating Cash Flow
-12.18-12.2-6.4-7.86-7.23-7.32
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
-65.78-63.45-14.344.93-4.92-
Investing Cash Flow
-65.78-63.45-14.344.93-4.92-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
127.69127.7159.42.070.1111.28
Repurchase of Common Stock
-36.53-36.13-0.1-0.05-0.08-0.06
Other Financing Activities
------0.34
Financing Cash Flow
91.1691.5759.292.030.0310.88

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.060.10-0.02-00
Net Cash Flow
13.2616.0238.55-0.92-12.123.57

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-6.1-8.2-5.48-5.01-3.22-3.99
Unlevered Free Cash Flow
-6.1-8.2-5.48-5.01-3.22-3.99

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
2.35-2.613.5-1.351.650.32
SEC Filings: 10-K · 10-Q